Anamorelin 50mg Tablets

Anamorelin 50mg Tablets represent a novel therapeutic class designed to combat cancer cachexia, a debilitating syndrome characterized by severe weight loss, muscle wasting, and loss of appetite. Pharmacologically, the medication acts as a selective agonist of the ghrelin receptor (also known as the growth hormone secretagogue receptor 1a or GHSR-1a).

Ghrelin is often referred to as the “hunger hormone,” a peptide naturally secreted by the stomach that signals the brain to eat. In patients with advanced cancer, the body’s natural ghrelin response is often blunted or overwhelmed by inflammatory cytokines. Anamorelin 50mg Tablets mimic the action of this hormone by binding to receptors in the hypothalamus.

This binding triggers a dual effect: it directly stimulates appetite and simultaneously activates the production of growth hormone (GH) and insulin-like growth factor-1 (IGF-1). Unlike traditional appetite stimulants that may only increase fat tissue or water retention, the elevation of IGF-1 promotes protein synthesis. This anabolic action helps preserve or increase lean body mass (muscle tissue), directly addressing the metabolic imbalance that drives cachexia.

Indications / Uses of Anamorelin 50mg Tablets

Anamorelin 50mg Tablets are indicated for the treatment of cancer cachexia in adult patients with non-small cell lung cancer, gastric cancer, pancreatic cancer, or colorectal cancer. It is specifically prescribed to address the complex metabolic components of this syndrome:

• Weight Loss and Muscle Wasting: Indicated for patients who have experienced significant involuntary weight loss, specifically the loss of skeletal muscle mass, which correlates with poor prognosis and reduced quality of life.
• Anorexia (Loss of Appetite): Used to stimulate appetite in patients who have a reduced desire to eat, helping to increase caloric intake.
• Refractory Cachexia: Often employed when nutritional counseling and standard dietary interventions have failed to stabilize the patient’s weight.
• Dosing Regimen: The standard adult dosage typically involves taking 100mg once daily (often administered as two 50mg tablets) on an empty stomach.

Key Features

• Ghrelin Mimetic: By functioning as an oral ghrelin mimetic, it utilizes a physiological pathway to stimulate hunger, rather than relying on central nervous system sedation or steroid-based mechanisms.
• Anabolic Effect: A key differentiator is its ability to increase IGF-1 levels, promoting the building of muscle rather than just fat accumulation.
• Oral Administration: Formulated as a tablet, it offers a non-invasive route of administration, which is crucial for frail patients who may wish to avoid injections or infusions.
• Quality of Life: Clinical trials have demonstrated improvements in body weight and appetite, which are critical factors for the psychological and physical well-being of cancer patients.

Storage for Anamorelin 50mg Tablets

To ensure the pharmacological stability of Anamorelin 50mg Tablets, proper storage is essential. Store the medication at controlled room temperature, typically between 20°C and 25°C (68°F to 77°F). Brief excursions are permitted between 15°C and 30°C (59°F to 86°F).

Keep the tablets in their original blister pack or bottle until just before administration to protect them from moisture and light. Do not store the medication in humid environments like bathrooms. Ensure the container is kept securely out of the reach and sight of children and pets.

Important Note on Anamorelin 50mg Tablets

Treatment with Anamorelin 50mg Tablets requires careful cardiac monitoring. The medication can prolong the PR and QT intervals on an electrocardiogram (ECG). Therefore, it is generally contraindicated or used with extreme caution in patients with heart conditions such as complete heart block, congestive heart failure, or those taking other drugs known to prolong the QT interval.

Hyperglycemia (high blood sugar) is a potential side effect, as the drug influences growth hormone pathways which can reduce insulin sensitivity. Patients with diabetes or glucose intolerance should have their blood sugar levels monitored regularly.

The medication is metabolized by the liver (CYP3A4); liver enzymes should be checked periodically. Common side effects include nausea, palpitations, and fatigue.

It should be taken on an empty stomach (at least 1 hour before or 2 hours after a meal) because food can significantly decrease the absorption of the drug. There is a risk of fetal harm; effective contraception is recommended for females of reproductive potential during treatment.